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Activation of protein kinasc C (PKC) has been linked to the regulation of class II expression on endothclial cells by interferon-y (IFN-y). PKC 
subtypes in cndothelial cells were analyzed using three different approaches, the immunopcroxidase staining of native and IFN-7 stimulatrd cells 
cultured on chamber slides as well as immuno- and Northern blotting. All approaches revealed that of the conventional subtypes. Q is the 
predominant form of PKC in endothelial cells. Even though IFN-y is able to induce PKC translocation to particulate fractions, no translocation 
was detected in histological stainings. Western blot studies as well as mRNA studies rcwaled that IFN-7 is unable to increase the total amount 
of PKC in cndothclial cells. 
Endothclial cell; Protein kinase C: Interferon-gamma: Diacylglycerol 
I. INTRODUCTION 
In signalling via phosphatidylinositol (PI)-dependent 
pathway, binding of ligand to its receptor results in the 
breakdown of phosphatidyl 4.5.bisphosphate (PIP?) 
and formation of inositol 1.4.5-trisphosphate (1P3) and 
diacylglycerol (DAG). The former elevates the intracel- 
lular Ca” concentration and the latter activates protein 
kinase C (PKC). Although the hydrolysis of phosphoi- 
nositolbisphosphate (PIP,) was thought to be the sole 
mechanism for PKC activation. recent studies suggest 
that there are several additional signal pathways to pro- 
vide DAG. For instance. phosphatidylcholine (PC) may 
also be hydrolysed to produce DAG [l]. Hydrolysis of 
PC by either phospholipases C or D can lead to DAG 
production [2-j]. Phospholipase C (PLC) hydrolysis of 
PC is followed by an increase in DAG and phosphoryl- 
choline whereas increases in choline. phosphatidic acid 
(PA) and finally DAG suggest that phospholipase D is 
involved. 
Protein kinase C is a family of closely related proteins 
that differ in tissue distribution. co-fxtor dependency 
and substrate specificity [6.7]. The relative distribution 
of PKC subspecies varies markedly with different areas 
of tissues and cell types examined. PKC subtypes 2. PI. 
PII and y were described first [8.9]. More recently also 
cDNA clones for 6. E and 5 subtypes have been pre- 
pared [lo]. The latest member of this family, PKCII. was 
described this year [ 1 I], The conventional PKC sub- 
types 01. /Zl and y are characterized by their requirement 
for Ca’+, phospholipids and DAG. The other group of 
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PKC isotypes 6. E. 5 and 11. the novel isotypes. seems to 
be independent of Ca” [ 113. 
Earlier studies in this laboratory have revealed that 
protein kinase C is induced following IFN-y treatment 
in endothelial cells [12]. Protein kinase C subtypes in 
non-stimulated and IFN-y-stimulated endothelial cells 
are now described. 
2. MATERIALS AND METHODS 
Four to I?-day-old DA rats wcrc operated with a modification of 
the method of Kastcn [ 131. In some cspcriments the cells growing in 
flasks or Lab-Tek chamber slides (Miles Scientific. IL. USA) were 
stimulated with 100 U/ml recombinant rat IFN-y (a gift from Dr P.H. 
v.d. Mcide. Rijswijk, The Netherlands) for dilTicrent time periods. 
2.2. 1trrtr~rttro~~trrosi~i~t.s~~ stcti rirtgs
Cells cultured in chamber slides wcrc fixed with acetone for IO min. 
All subscqucnt proccdurcs were carried out inside a humidified bos. 
The spccimcns were exposed for 30 min to mouse monoclonal anti- 
bodies: monoclonal anti-protein kinasc C type a (type 3). typcp (type 
11 and type y (type I. all purchased from Scikagaku Kogyo Co.. Ltd.. 
Tokyo, Japan). The secondary antibody used was peroxidasc-conju- 
gatcd rabbit anti-mouse Ig and the third antibody was pcroxidase- 
conjugdtcd goat anti-rabbit lg. Aminoethyl carbatsolc and hy- 
drogen peroxide were used as a chromogen and substrate. rcspcctively. 
to dcmonstratc antigen in cells. Mayer’s Hcmalaun (Merck. 
Darmstadt. Germany) was used to counter stain. 
IO x IO’ cells wcrc lysed with IO vols ol’ SDS-PAGE sample bun‘cr 
(2% SDS. 100 mM dithiothrcitol. 60 mM Tris. pi-l 6.8. 0.01% Bro- 
mophcnol blue). mixed vigorously and boiled I’or 5 min. To shear the 
chromosomal DNA the sample was sonicatcd l’or 70 s at full force. The 
sample was then centrifuged at IO 000 x 1: for IO min. the supcrnatant 
was recovered and liozcn at -20°C. SDS-PAGE was made using an 
8% gel and Mighty Small II slab gel clcctrophoresis unit (HoclTcr 
Scientific Instruments. San Francisco. USA). Samples wcrc applied IO 
four wells. Rainbow protein molecular weight markers (92.5 kDa, 69 
kDa. 46 kDa. 30 kDa, 21 kDa and 14.3 kDa) wcrc used HIS standard. 
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Electrophoretic transfer was made by ML:: Transfer apparatus Wocf- 
fcr Scientific instruments. San Francisco. CA) following the manufac- 
turer’s instructions using nitrocellulose filters (Hybond) and transfer 
buffer containing Tris 25 mM, glycinc I30 mM. methanol 20% (pH 
8.3). After blotting the filter was allowed to dry completely in order 
to minimize the chance of the transferred proteins being lost during 
subsequent steps. When the tilter was cut in slices. rinsed several times 
with PBS and incubated for 2 h in the blocking solution (3% BSA/PBS) 
with agitation. washed twice with PBS and incubated with different 
anti-PKC antibodies overnight. After the PKCsubtype antibody incu- 
bation filter pieces were washed twice with PBS. exposed to pcroxi- 
dase-conjugated rabbit anti-mouse antibody for I h. washed 4 times 
with PBS and esposed to peroxidase-conjugated goat anti-rabbit anti- 
body for I h. After the final incubation, filter pieces were washed once 
more and developed with aminoethyl carbatsolc and hydrogen 
peroxide. 
2.4. Eslrcrcriou md atwl~sis oJ’ RNA 
Poly (A*) RNA was extracted from IO’-IO’ cells. Where indicated 
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IFN-)I was added at 100 U/ml. H-7 at 2 or 20 PM and cycloheximide 
at 150 fig/ml. Poly (A*) mRNA was bound to oligo-dT cellulose 
directly from cell lysates and elutcd as described [l4]. 2Opg ofmRNA 
was dissolved in sample buffer (20 mM morpholinopropanesulfonic 
acid. 50% formamide. 2.2 M formaldehyde. 5% Ficoll, 5 mM EDTA. 
0.04% Bromophcnol blue), size-fractionated in formaldehyde-agarosc 
(0.8%) gels and transferred to Immobilon-N transfer membranes (Mil- 
liporc Corporation. Bedford, MA) in 20 x SSC (I x SSC is I.50 mM 
NaCI. I5 mM sodium citrate, pH 7.0) for 24 h. Hybridizations were 
carried out at +42”C for 20 h in a hybridization mixture containing 
5 x Denhardt’s solution (100 x Denhardt’s solution is 2% each of 
Ficoll. polyvinylpyrrolidone and bovine serum albumin), 5 x SSC. 100 
mM PO, (21.9 mM K&PO4 and 78.1 mM KH:POJ. 50% formamide. 
100 pg/ml salmon sperm DNA and I00 @ml yeast transfer RNA. 
Post-hybrization washes were done twice at room temperature. twice 
at +6O”C with 2 x SSC containing 0.1% SDS and twice with 0.2 x SSC 
containing 0.1% SDS at +60°C for I5 min. The filters were cxposcd 
to Kodak XAR-5 film at -70°C for periods of 24 h to I4 days. 
Radioactive signals were quantitated from the autoradiograms with 
Fig. I, Endothelial cells on chamber slides wcrc stained with antibodies to conventional PKC isotypes. Anti-cc antibody stainingwas strongly positive 
when both control cells (Fig. la) or IFN-y-treated cells (Fig. I b) were used, PKCcr being mainly associated IO the pcrinuclcar area. Stainings with 
anti-p and anti-y antibodies were weak and ncgativc. respcctivcly (data not shown). Negative control with an irrelcvanl antibody was also done 
and was found to bc blank. 
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a dcnsitomctric scanner (Helena Laboratories. Beaumont. TX). The 
PKC a, /?l and y probes were purchased from American Type Culture 
Collection. The insert sizes in pUC vector were I .29. 1.70 and 1.40 kb. 
respectively. The cDNA for glyceraldehyde-3-phosphate-dehydro- 
genase (GADPH [15]), which has been shown to bc fairly invariably 
expressed and stimulated only by insulin in adipocyte cultures (ref) 
was a gift from Dr P. Fort (Montpellier. France) and used as an 
internal control for RNA loading. Nick-translations of cDNA using 
[a-JzP]dCTP (3000 Ci/mmol) were carried out according to the manu- 
facturcr’s instructions (Amersham. UK). 
3. RESULTS 
Activation of protein kinase C has been linked to 
regulation of class II expression on endothelial cells by 
IFN-y. I wanted to analyse further, which PKC sub- 
types are involved in endothelial activation. To do this 
three different approaches were used. the immuno- 
peroxidase staining of native and IFN-y-stimulated 
cells cultured on chamber slides as well as immuno- and 
Northern blottings. 
Endothelial cells were transferred to chamber slides 
and cultured in the presence of serum for 24 h. The cells 
were then fixed and stained with an immunoperoxidase 
technique applying monoclonal antibodies against PKC 
subtypes 01, p and y. Endothelial cells were strongly 
stained when anti-a antibody was used (Fig. 1). Staining 
with anti-8 antibody was much weaker and subtype y 
was not detectable. In these stainings PKCa was mainly 
associated in a granular fashion in the perizuclear area. 
In some experiments the cells were treated with IFN-y 
for 5 min, 15 min or 24 h to stimulate PKC. When 
endothelial cells were treated with IFN-y for 5 min a 
constant and reproducible 30% PKC translation 
(measured by histone translocation assay) and in- 
creased phorboldibutyrate (PI&) binding were seen 
[16]. In the same kind of experiment here. no difference 
was recorded in the subcellular location of PKC subtype 
01 between non-stimulated and IFN-y stimulated cells. 
The molecular weight of various PKC subtypes is 
known to be approximately 76 kDa. In Western blot 
analysis native cells or cells stimulated with IFN-y for 
24 h were lysed. the proteins were separated in SDS- 
Fig. 2. Western blot analysis was performed using native cells or cells 
stimulated with IFN-y for a positive band was detected bctwecn the 
MW markers 92 kDa and 69 kDa when anti PKC-zantibody was used 
(lane I). Anti-PKC-B staining was barely dctectablc (lane 2) and anti- 
PKC-y-staining was negative (lane 3). Lane 4 represents non-specilic 
background. 24 h IFN-y stimulus was not able IO increase the amount 
of PKC in endothelial cells (data not shown). 
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Fig. 3. Northern blot analysis was done using cDNA probes for PKC 
z. fi and y isotypes. This revealed that practically all mRNA in endo- 
thelial cells is of the u-subtype. IFN-y induction of endothelial cells 
had no effect on the mRNA levels of a. /I and y subtypes. 
PAGE electrophoresis and blotted to nitrocellulose fil- 
ters. A positive band was detected between the molecu- 
lar weight markers 92 kDa and 69 kDa when anti- 
PKCa antibody was used. Anti-PKCP antibody stain- 
ing was barely detectable and staining with anti-PKCy 
antibody was negative (Fig. 2). Once again no difference 
was seen between IFN-y stimulated and native cells 
(data not shown) indicating that IFN-y could not in- 
crease the amount of PKC in endothelial cells. 
Finally poly(A’)RNA was isolated from cultured en- 
dothelial cells. Northern blot analysis revealed that 
practically all PKC-mRNA was of the 01 subtype. Only 
traces of fl- and y-subtype message were detectable at 
the mRNA level. IFN-y did not have any effect on the 
amount of mRNA message of the subtypes (Fig. 3). 
Taken together. all three approaches revealed that of 
the conventional PKC subtypes, Q! is the predominant 
form of protein kinase C in endotheIial cells. Even 
though IFN-7 is able to induce PKC translocation and 
increase phorboldibutyrate binding, I was unable to 
show any translocation of PKC to particulate fractions 
in histological stainings. Western blot studies as well as 
mRNA studies revealed that IFN-y is unable to in- 
crease the total PKC amount in endothelial cells. 
4. DISCUSSION 
The signal transduction pathway involving calcium 
mobilization and PKC activation is a mechanism uti- 
lized by several hormones. neurotransmitters. and 
growth factors [2.17-191. Activation of PKC has 
emerged as a major mechanism in transducing signals 
induced by several cytokines. e.g. TNF, IL-I and inter- 
ferons [2.17]. 
A few interferon-induced transmembrane signalling 
processes are known to occur via the PKC pathway. In 
huma ~i~r~u’illasr.s, CL and fi interferons stimulate a tran- 
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sient two- to threefold increase in the concentration of 
DAG and lPJ [19]. PKC is also known to be involved 
in murine macrophage activation by IFN-B [20]. Fur- 
thermore. IFN-cr selectively activates the /l isoform of 
PKC through phosphotidylcholine hydrolysis in HeLa 
cells [4]. IFN-y induces DAG release and lP3 formation 
within 30 s in Daudi cells and it also modulates PKC 
activity in murine macrophages [19,21]. We have re- 
ported that PKC mediates IFN-7 induced class II ex- 
pression in endothelial cells [I 2,161. In other cell types 
than endothelial cells the role of PKC activation to 
MHC class II upregulation is controversial [22]. 
The relative activity and individual pattern of expres- 
sion of multiple PKC subspecies in several tissues and 
cell types have recently been examined extensively. PKC 
01 is widely distributed in many tissues and cell types like 
in brain tissue. HL-60 cells, T cells and platelets [7,23- 
251. In contrast, PKC PI and PII isotypes are expressed 
in the brain as well as in several other tissues like murine 
thymocytes, human T cells. human lymphoid cell lines 
and human platelets [7,24.26,27]. PKC /3 is the predomi- 
nant isotype in spleen tissue and in leukocytes. PKC 
with y sequence is expressed solely in the central ner- 
vous tissue, and is not found in any other tissue or cell 
type analysed so far [7]. In general, it seems to be that 
one cell type contains more than one PKC isotype. 
These subspecies apparently show a distinct intracellu- 
lar location. depending on the state of differentation or 
proliferation. Very little is known about he distribution 
of the novel isoenzymes encoded by 6, E, 5 and 11 se- 
quences. PKC E is known to be expressed in murine 
thymocytes as well as in cultured fetal chick neurons 
[28,29]. Mouse cell lines of neuronal origin express PKC 
E and c in addition to PKC Q [30]. PKC 11. the latest 
member of the family is predominantly expressed in 
lung and skin [I 11. The results presented in this paper 
suggest that PKC-a is the predominant isotype in en- 
dothelial cells. 
Protein kinase C activity has been linked to its 
translocation from cell cytosol to particulate fractions 
of the cell, to cell membrane [31,32] or to nuclear en- 
velope [33]. However, the majority of PKC activity in 
non- dividing cultured porcine aortic endotheiial ceiis is 
found in the cytoplasm, whereas in vigorously prolifera- 
ting cells, >lore than half of the total activity is found 
in the memurane fraction [34]. This agrees with our 
results in immunoperoxidase stainings where no 
translocation was seen after IFN-1/ treatment. We 
plated endothelial cells on chamber slides sparsely to 
detect single cells and therefore these cells were dividing. 
Furthermore only a 30% increase in translocation was 
seen in bovine pulmonary artery endothelial cells when 
treated with the PKC activator, phorbol l2-myristate 
l3-acetate [35]. measured by histone translocation and 
also in our endothelial cells when treated with IFN-)I 
[ 161. In this system PKC activation reduces already after 
IO min after IFN-y stimulation. PKC activation in this 
endothelial cell system is so transient that it is unlikely 
that new PKC protein synthesis would have had time 
to take place. Stimulation of peritoneal murine macro- 
phages with IFN-y leads to PKC activation but did not 
alter the subcellular distribution of the enzyme [21]; in 
rat brain and lymphocytes half of the tissue PKC con- 
tents is continuously bound to membranes [36]. It is also 
known that some biological responses mediated by 
PKC may be achieved by activation of less than 5% of 
the total enzyme activity [37]. On the contrary in human 
T cells about a IO-fold translocation has been observed 
in histone translocation assay [31] and in these cells this 
subcellular redistribution is also seen in immunocyto- 
chemical stainings [32]. The results presented in this 
paper suggest that PKCcw. is the predominant subtype in 
endothelial cells, and that there is some PKC@ but no 
y subtype present. Even though IFN-7 is able to cause 
PKC activation (measured by histone translocation- 
and phorbol binding assays) it does not increase the 
amount of PKC as measured by immunoperoxidase 
staining, Western- or Northern blotting. 
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